GRTS Gritstone bio, Inc. Stock Quote

GRTS [NASD]

Index	-	P/E	-	EPS (ttm)	-1.73	Insider Own	3.77%	Shs Outstand	49.43M	Perf Week	15.63%
Market Cap	644.23M	Forward P/E	-	EPS next Y	-2.22	Insider Trans	-0.27%	Shs Float	47.58M	Perf Month	55.99%
Income	-70.40M	PEG	-	EPS next Q	-0.53	Inst Own	71.00%	Short Float	13.29%	Perf Quarter	36.77%
Sales	44.80M	P/S	14.38	EPS this Y	1.00%	Inst Trans	2.40%	Short Ratio	8.49	Perf Half Y	1.27%
Book/sh	3.62	P/B	3.74	EPS next Y	-74.80%	ROA	-34.60%	Target Price	-	Perf Year	313.44%
Cash/sh	3.60	P/C	3.76	EPS next 5Y	-	ROE	-45.70%	52W Range	2.54 - 35.20	Perf YTD	243.65%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-63.60%	52W High	-61.53%	Beta	-
Dividend %	-	Quick Ratio	8.20	Sales past 5Y	-	Gross Margin	-	52W Low	434.12%	ATR	0.90
Employees	181	Current Ratio	8.20	Sales Q/Q	460.00%	Oper. Margin	-	RSI (14)	76.12	Volatility	9.41% 8.59%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	26.80%	Profit Margin	-	Rel Volume	1.74	Prev Close	13.54
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	745.24K	Price	13.54
Recom	2.00	SMA20	31.92%	SMA50	55.86%	SMA200	37.83%	Volume	0	Change	0.00%

Jan-20-21

Downgrade

Robert W. Baird

Outperform → Underperform

Jul-26-19

Initiated

Robert W. Baird

Outperform

$17

Mar-15-19

Initiated

Raymond James

Outperform

Mar-07-19

Initiated

H.C. Wainwright

Buy

$17

Oct-23-18

Initiated

Goldman

Neutral

$18

Oct-23-18

Initiated

BTIG Research

Buy

$26

Sep-17-21 07:02AM	Gritstone Announces Dosing of First Solid Tumor Patient with Optimized SLATE Off-the-Shelf Mutant KRAS-directed Neoantigen Immunotherapy in Phase 2 Clinical Trial GlobeNewswire
07:01AM	Gritstone Announces Positive Clinical Data with GRANITE (Individualized Neoantigen Immunotherapy Program) during ESMO 2021 and Launch of Randomized Clinical Trial Program in Colorectal Cancer with Registrational Intent GlobeNewswire
Sep-16-21 04:01PM	Gritstone Announces Private Placement Financing of $55.0 Million GlobeNewswire +5.86%
05:55AM	3 Explosive Biotech Stocks That Could 10X in 10 Years Motley Fool
Sep-09-21 04:05PM	Gritstone to Host Data Update on Neoantigen Oncology Programs for the Treatment of Solid Tumors During ESMO 2021 GlobeNewswire
Sep-07-21 04:00PM	Gritstone Announces Presentations at Two Investor Conferences in September GlobeNewswire +7.84%
Aug-17-21 07:00AM	Gritstone and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine Program (CORAL) Against SARS-CoV-2 Variants of Concern GlobeNewswire +8.50%
Aug-16-21 04:00PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Aug-11-21 07:00AM	Gritstone to Host Key Opinion Leader Webinar on its Neoantigen Oncology Programs GlobeNewswire
Aug-05-21 04:00PM	Gritstone Reports Second Quarter 2021 Financial Results and Business Update GlobeNewswire +8.42%
10:50AM	10 Best Biotech Stocks to Buy According to Alan Fraziers Frazier Healthcare Partners Insider Monkey
Jul-27-21 02:51AM	If You Had Bought Gritstone bio (NASDAQ:GRTS) Stock A Year Ago, You Could Pocket A 108% Gain Today Simply Wall St.
Jul-15-21 04:00PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jun-23-21 08:00AM	Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Financial Officer GlobeNewswire +5.06%
Jun-17-21 08:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jun-07-21 08:00AM	Gritstone to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference GlobeNewswire
Jun-01-21 08:00AM	Gritstone Announces Changes to Its Board of Directors GlobeNewswire
May-28-21 03:36AM	Companies Like Gritstone bio (NASDAQ:GRTS) Are In A Position To Invest In Growth Simply Wall St.
May-24-21 04:00PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-06-21 10:15AM	Gritstone Oncology, Inc. (GRTS) Q1 Earnings and Revenues Top Estimates Zacks
09:01AM	Gritstone Reports First Quarter 2021 Financial Results and Business Highlights GlobeNewswire
May-03-21 08:00AM	Gritstone Oncology Changes its Name to Gritstone bio to Reflect Expanded Therapeutic Focus GlobeNewswire
Mar-29-21 07:00AM	Gritstone Announces First Person Dosed with its Second-Generation COVID-19 Vaccine in Phase 1 Study Conducted and Supported by NIAID/IDCRC GlobeNewswire -10.19%
02:54AM	What Type Of Shareholders Own The Most Number of Gritstone Oncology, Inc. (NASDAQ:GRTS) Shares? Simply Wall St.
Mar-15-21 06:00AM	Could These 3 Stocks Be 10-Baggers in 2021? Motley Fool
Mar-13-21 06:56AM	3 Biotech Stocks That Have Already Rocketed Higher in 2021 Motley Fool
Mar-11-21 10:15AM	Gritstone Oncology, Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates Zacks +6.85%
09:01AM	Gritstone Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights GlobeNewswire
Mar-08-21 08:00AM	Gritstone Announces Promotions Within its Leadership Team GlobeNewswire
Mar-03-21 12:30PM	Gritstone Oncology, Inc. (GRTS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Zacks -7.55%
Mar-02-21 08:00AM	Gritstone to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire +6.32%
Feb-11-21 06:55AM	4 Top COVID Stocks to Buy in February Motley Fool
Feb-01-21 04:21PM	Biotech Stock Gritstone Stumbles On Gilead Tie-Up, While Arcus Pops Investor's Business Daily -5.52%
06:17AM	Gritstone Oncology shares soar 44% premarket on news of collaboration with Gilead to develop HIV therapy MarketWatch
06:00AM	Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstones Vaccine Platform Technology for HIV Cure Business Wire
04:10AM	Gritstone Spikes on Gilead Partnership to Develop HIV Vaccine TheStreet.com
Jan-27-21 08:19AM	Moving Average Crossover Alert: Gritstone Oncology (GRTS) Zacks -15.86%
Jan-23-21 06:14AM	Is This Under-the-Radar COVID Stock the Next Moderna? Motley Fool
Jan-21-21 08:16AM	Trade Carefully With Soaring Gritstone Oncology TheStreet.com
08:05AM	The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga
Jan-20-21 07:33PM	Gritstones Unique Approach Can Set Its 2nd Gen COVID-19 Vaccine Apart, Says Analyst TipRanks +14.46%
04:34PM	Gritstone Touches Record, Defying Analysts Double Downgrade Bloomberg
04:13PM	Pfizer Says Covid Jab Could Battle U.K. Variant; Gritstone Expands Its Gain Investor's Business Daily
12:13PM	Biotech Stock Roundup: ALXN Pauses Study, ACRS & GRTS Surge, & Other Updates Zacks
09:25AM	Gritstone (GRTS) to Begin Coronavirus Vaccine Study, Stock Up Zacks
08:00AM	Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine GlobeNewswire
Jan-19-21 03:27PM	Gritstone Soars Due to Progress on COVID Vaccine TheStreet.com +248.51%
06:00AM	Gritstone Advances Second Generation COVID-19 Vaccine CORAL Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2 GlobeNewswire
Jan-11-21 08:00AM	Gritstone Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire +9.25%
Dec-28-20 08:00AM	Gritstone Oncology Announces Private Placement Financings Totaling $125 Million GlobeNewswire -12.32%
Dec-23-20 08:33AM	Gritstone Oncology Announces $110 Million Private Placement GlobeNewswire +24.55%
Dec-04-20 10:15AM	Here is What Hedge Funds Think About Gritstone Oncology, Inc. (GRTS) Insider Monkey
Nov-05-20 09:01AM	Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights GlobeNewswire
Nov-02-20 08:00AM	Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATE GlobeNewswire
Sep-21-20 09:27AM	Can Gritstone Oncology (NASDAQ:GRTS) Afford To Invest In Growth? Simply Wall St. -8.79%
Sep-15-20 08:00AM	Gritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare Conference GlobeNewswire
Sep-08-20 08:00AM	Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September GlobeNewswire +5.92%
Aug-06-20 05:19PM	3 Strong Buy Healthcare Stocks Under $5 That Could See Outsized Gains TipRanks
Aug-05-20 10:25AM	Gritstone Oncology, Inc. (GRTS) Reports Q2 Loss, Misses Revenue Estimates Zacks
09:01AM	Gritstone Oncology Reports Second Quarter Financial Results and Recent Highlights GlobeNewswire
Aug-03-20 12:31PM	Analysts Estimate Gritstone Oncology, Inc. (GRTS) to Report a Decline in Earnings: What to Look Out for Zacks
08:00AM	Gritstone Oncology to Present at Two Upcoming Investor Conferences in August GlobeNewswire
Jul-22-20 02:28PM	Do Institutions Own Gritstone Oncology, Inc. (NASDAQ:GRTS) Shares? Simply Wall St.
Jun-24-20 08:00AM	Gritstone Oncology to Present Clinical Data from Ongoing GRANITE and SLATE Phase 1 Studies During Investor Webcast on July 13 GlobeNewswire
Jun-14-20 08:59PM	Hedge Funds Are Done Selling Gritstone Oncology, Inc. (GRTS) Insider Monkey
Jun-10-20 08:00AM	Gritstone Oncology Announces the Addition of Jean-Charles Soria, M.D., Ph.D., to its Scientific Advisory Board GlobeNewswire
Jun-04-20 08:00AM	Gritstone Oncology to Present at Two Upcoming Investor Conferences in June GlobeNewswire
May-22-20 09:15AM	Gritstone Oncology (GRTS): Strong Industry, Solid Earnings Estimate Revisions Zacks +5.16%
May-10-20 10:14AM	Analysts Have Made A Financial Statement On Gritstone Oncology, Inc.'s (NASDAQ:GRTS) First-Quarter Report Simply Wall St.
May-07-20 11:15AM	Gritstone Oncology Inc (GRTS) Reports Q1 Loss, Tops Revenue Estimates Zacks
09:01AM	Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights GlobeNewswire
May-01-20 08:00AM	Gritstone Oncology Announces the Appointment of Dr. Elaine V. Jones as Chair of the Board of Directors GlobeNewswire -9.99%
Apr-06-20 08:00AM	Gritstone Oncology Announces the Appointment of Veteran Legal Executive Rahsaan Thompson as General Counsel GlobeNewswire +9.02%
Mar-13-20 08:30AM	Earnings Update: Gritstone Oncology, Inc. Just Reported And Analysts Are Boosting Their Estimates Simply Wall St. +9.75%
Mar-11-20 10:25AM	Gritstone Oncology, Inc. (GRTS) Reports Q4 Loss, Misses Revenue Estimates Zacks -5.26%
09:01AM	Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights GlobeNewswire
Feb-25-20 04:00PM	Gritstone Oncology to Present at Two Investor Conferences in March GlobeNewswire
12:09PM	Analysts: 3 Healthcare Stocks to Buy on Coronavirus Weakness TipRanks
Jan-08-20 04:00PM	Gritstone Oncology to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-01-20 11:27AM	We Think Gritstone Oncology (NASDAQ:GRTS) Needs To Drive Business Growth Carefully Simply Wall St.
Dec-16-19 07:36AM	Is Gritstone Oncology, Inc. (GRTS) A Good Stock To Buy? Insider Monkey -11.63%
Dec-12-19 07:38AM	The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win Benzinga -11.37%
05:05AM	Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE GlobeNewswire
Dec-09-19 08:00AM	Gritstone Oncology to Webcast a Review of the Clinical Immunogenicity Data from its Neoantigen-based Immunotherapies that will be Presented at the ESMO Immuno-Oncology Congress GlobeNewswire
Nov-26-19 08:00AM	Gritstone Oncology to Present at the Piper Jaffray Annual Healthcare Conference GlobeNewswire -5.33%
Nov-12-19 09:01AM	Gritstone Oncology Reports Third Quarter 2019 Financial Results and Recent Highlights GlobeNewswire
Nov-06-19 10:30AM	Will Gritstone Oncology, Inc. (GRTS) Report Negative Q3 Earnings? What You Should Know Zacks
Nov-05-19 08:05AM	Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy GlobeNewswire
Oct-31-19 08:00AM	Gritstone Oncology to Webcast Investor Event Reviewing its Neoantigen-based Immunotherapies During SITC Conference GlobeNewswire +5.87%
Oct-07-19 08:00AM	Gritstone Oncology Announces Upcoming Presentation on Novel Shared Neoantigens Included within Off-The-Shelf SLATE Immunotherapy at SITC 2019 Annual Meeting GlobeNewswire
Sep-27-19 08:22AM	Investors Who Bought Gritstone Oncology (NASDAQ:GRTS) Shares A Year Ago Are Now Down 37% Simply Wall St. -5.59%
Sep-26-19 08:00AM	Gritstone Oncology to Present at Cantor Global Healthcare Conference GlobeNewswire
Sep-12-19 08:00AM	Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. Jones GlobeNewswire -6.85%
Aug-14-19 03:40PM	Its not just Bloom Energy: Half of last years Bay Area IPO stocks are underwater American City Business Journals
08:00AM	Gritstone Oncology Announces First Patient Dosed with SLATE, its Off-The-Shelf Neoantigen Immunotherapy GlobeNewswire
Aug-12-19 09:01AM	Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights GlobeNewswire
Jul-08-19 08:00AM	Gritstone Oncology Announces the Appointment of Dr. Vijay Yabannavar, a Biopharma Leader with Over 30 Years of Experience, as Executive Vice President of Manufacturing and Technical Operations GlobeNewswire
Jun-05-19 08:00AM	Gritstone Oncology to Present at Two Upcoming Investor Conferences in June GlobeNewswire
Jun-03-19 11:00AM	Health Care Digest: Why California biotech thrives, small company looks to crash NASH bash, meeting up at BIO American City Business Journals
May-30-19 08:00AM	Gritstone Oncology to Host Event with Oncology Key Opinion Leaders Discussing Neoantigen-based Immunotherapy During ASCO Annual Meeting GlobeNewswire

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jones Erin	See Remarks	Sep 08	Option Exercise	0.34	2,000	690	22,000	Sep 10 04:19 PM
Jones Erin	See Remarks	Sep 08	Sale	11.37	2,000	22,748	20,000	Sep 10 04:19 PM
Rousseau Raphael	See Remarks	May 27	Option Exercise	0.76	2,900	2,201	2,900	Jun 03 06:34 PM
Rousseau Raphael	See Remarks	May 27	Sale	9.00	2,900	26,112	0	Jun 03 06:34 PM
Yelensky Roman	See Remarks	Mar 08	Option Exercise	0.76	50,724	38,500	183,948	Apr 16 05:13 PM
Rousseau Raphael	See Remarks	Jan 20	Option Exercise	0.76	10,000	7,600	10,000	Jan 21 05:11 PM
Rousseau Raphael	See Remarks	Jan 20	Sale	25.07	10,000	250,705	0	Jan 21 05:11 PM
Rousseau Raphael	See Remarks	Jan 19	Option Exercise	0.76	20,000	15,200	20,000	Jan 21 05:11 PM
Rousseau Raphael	See Remarks	Jan 19	Sale	17.53	20,000	350,564	0	Jan 21 05:11 PM
Yelensky Roman	See Remarks	Jan 19	Sale	22.10	10,000	221,029	133,224	Jan 21 05:06 PM
Woiwode Thomas	Director	Dec 30	Buy	3.71	1,347,709	5,000,000	1,347,709	Jan 04 06:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience